Can Pfizer's Stock Break This Disappointing Streak?
(NYSE: PFE) is one of the largest healthcare companies in the world. It was founded in 1849 and has since become an iconic name in healthcare.
It has developed many medicines over the years; most recently, it has been known for developing its highly successful COVID vaccine Comirnaty. Growth and innovation have enabled the company to become a household name and a leader in healthcare.
Investors, however, have been having doubts about the business and its ability to grow in the future. In the past three years, the stock has produced negative returns. Since 2022, It has lost more than half its value. Can the stock break its downward streak, and finish this year in positive territory?
Source Fool.com
Pfizer Inc. Stock
€22.60
2.590%
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a slightly positive potential of 19.5% for Pfizer Inc. compared to the current price of 22.6 €.
